Market Movers: Nike Exploding Higher on Insider Buying

Photo of Ian Cooper
By Ian Cooper Published

Quick Read

  • Nike CEO Elliott Hill bought 16,400 shares for about $1 million. This follows news that Apple’s Tim Cook bought $3 million worth of Nike stock.

  • The U.S. FDA granted priority review of the Axsome’s marketing application seeking a label expansion for its depression therapy AXS-05 in Alzheimer’s disease agitation.

  • Nvidia asked TSMC to help ramp up production of its H200 artificial intelligence chips.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Market Movers: Nike Exploding Higher on Insider Buying

© 24/7 Wall St.

Oversold shares of Nike (NYSE: NKE | NKE Price Prediction) are on the run.

All on news that CEO Elliott Hill bought 16,400 shares for about $1 million. This follows news that Apple’s Tim Cook bought $3 million worth of Nike stock. Cook, who has been on the NKE board since 2005, bought 50,000 shares at an average price of $58.97. Robert Swan, another Nike director, bought about $500,000 of stock on Dec. 22 at an average price of $57.54.

All after Nike suffered with China sales, declining gross margins, and a cautious outlook.

Technically, after catching strong support at about $57, the oversold shoe giant is starting to pivot higher. Last trading at $62, it’s also starting to pivot from overextensions on RSI, MACD, and Williams’ %R. From here, we’d like to see it initially refill its bearish gap at around $66.20 a share over the next few days.

Axsome Therapeutics

Shares of Axsome Therapeutics (NASDAQ: AXSM) are up 18%, or by $28.17 a share.

All on news the U.S. FDA granted priority review of the company’s marketing application seeking a label expansion for its depression therapy AXS-05 in Alzheimer’s disease agitation. The U.S. FDA issued April 30, 2026, as its target action date.

“Up to 76% of people with Alzheimer’s disease experience agitation, representing a significant unmet medical need for patients and their caregivers, and currently, there is a dearth of approved treatments. We look forward to continuing to work with the FDA for the remainder of the review,” said Herriot Tabuteau, MD, CEO, as quoted in a company press release. 

Taiwan Semiconductor 

Shares of Taiwan Semiconductor (NYSE: TSM) are up about $5.35 a share.

Reportedly, Nvidia asked TSMC to help ramp up production of its H200 artificial intelligence chips, as noted. by Reuters. “Chinese technology companies have placed orders for more than 2 million H200 chips for 2026, while Nvidia currently holds just 700,000 units in stock,” they added.

“The exact additional volume Nvidia intends to order from TSMC remains unclear, they said. A third source said Nvidia has asked ‌TSMC to begin production of the additional chips, and work is expected to start in the second quarter of 2026.”

Photo of Ian Cooper
About the Author Ian Cooper →

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618